BioCardia falls short of Nasdaq minimum stockholders' equity requirement
BCDA•BioCardia received a Nasdaq noncompliance notice after reporting stockholders’ equity of $835,000 on September 30, 2026, below the $2.5 million minimum. It plans to submit a compliance plan by January 4, 2027; the notice has no immediate impact on listing or trading.
1. Nasdaq notice
BioCardia received a Nasdaq notice on November 20, 2026, for failing to meet the Nasdaq Capital Market’s minimum stockholders’ equity requirement. Its stockholders’ equity was $835,000 as of September 30, below the $2.5 million minimum under Nasdaq Listing Rule 5550(b)(1).
2. Compliance plan
The company intends to submit a compliance plan by January 4, 2027. If Nasdaq accepts the plan, it may grant BioCardia up to 180 calendar days from November 20 to demonstrate compliance. The notice has no immediate listing or trading impact, and BioCardia common stock continues to trade on the Nasdaq Capital Market under BCDA.




